Health ❯ Drug Development

Clinical Trials

FDA Approval Preclinical Testing Product Pipeline Oral Medications Phase 3 Studies Weight Loss Drugs Research and Development Regulatory Approval Weight Management Antiviral Research Pain Relief Medications Efficacy Studies Experimental Treatments Neuropsychiatric Drugs Phase 3 Trials Market Approval Drug Approvals

Regeneron Beats Q4 and Charts 2026 Catalysts With FDA Decisions and Phase III Push

Analyst revisions signal a clearer 2026 growth path.

Eli Lilly Becomes First Health Care Company Valued at $1 Trillion

BioCryst to Acquire Astria in $700 Million Cash-and-Stock Deal to Bolster HAE Portfolio

Johns Hopkins Researchers Grow Vascularized Whole-Brain Organoid With Network-Level Activity

Duke's SBI-810 Shows Promise as Non-Opioid Painkiller in Preclinical Studies